Biosimilar to Enbrel Unanimously Recommended by FDA PanelBiosimilar to Enbrel Unanimously Recommended by FDA Panel
The US Food and Drug Administration's Arthritis Advisory Committee unanimously recommended approval of GP2015 as a biosimilar to Enbrel (etanercept). Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news
More News: Arthritis | Dermatology | Enbrel | Food and Drug Administration (FDA) | Health | Rheumatology | Skin